Clinical Pharmacokinetics

, Volume 19, Issue 1, pp 32–43 | Cite as

Influence of Exercise on the Pharmacokinetics of Drugs

  • M. A. van Baak
Drug Disposition

Summary

Since many patients with a wide variety of diseases are nowadays stimulated to adopt a physically active lifestyle, the question of the influence of exercise on the pharmacokinetics of drugs has become more and more relevant. Because exercise influences a large number of physiological factors that also determine the pharmacokinetics of drugs, including haemodynamics, metabolism, pH, temperature and gastrointestinal function, it can be expected to have an effect on the pharmacokinetic parameters (absorption, distribution, elimination) of certain agents. However, only a very limited number of studies has been directed towards this issue, and only a very few drugs have been studied. Nevertheless, it is clear that exercise does influence the pharmacokinetics of certain drugs, although the magnitude and direction of the effects vary. This is not surprising in view of the widely differing physicochemical properties of drugs, the many possible — often opposing — effects of exercise on the parameters affecting drug pharmacokinetics and the different types of exercise performed.

The chance of a clinically relevant effect of exercise on the pharmacokinetics of a particular drug is largest in those with a steep dose-response curve, a narrow therapeutic range, a need for continuity of therapeutic effectiveness and a relatively short half-life, in combination with intensive exercise of long duration.

If untoward drug effects occur during or after exercise, a change in the pharmacokinetics of the drug related to the exercise should be seriously considered as a possible cause.

Keywords

Propranolol Digoxin Absorption Rate Skin Temperature Renal Clearance 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adams WC. Influence of exercise mode and selected ambient conditions on skin temperature. Annals of the New York Academy of Sciences 301: 110–127, 1977PubMedCrossRefGoogle Scholar
  2. Arends BG, Bohm ROB, van Kemenade JE, Rahn KH, von Baak MA. Influence of physical exercise on the pharmacokinetics of propranolol. European Journal of Clinical Pharmacology 31: 375–377, 1986PubMedCrossRefGoogle Scholar
  3. Aslaksen A, Aanderud L. Drug absorption during physical exercise. British Journal of Clinical Pharmacology 10: 383–385, 1980PubMedGoogle Scholar
  4. Baak MA van, Mooij JMV, Schiffers PMH. Pharmacokinetics of antihypertensive drugs during exercise. Medicine and Science in Sports and Exercise 20 (Suppl.): S89, 1988Google Scholar
  5. Ballard BE. Pharmacokinetics and temperature. Journal of Pharmaceutical Sciences 63: 1345–1358, 1974PubMedCrossRefGoogle Scholar
  6. Barkve TF, Langseth-Manrique K, Bredesen JE, Gjesdal K. Increased uptake of transdermal glyceryl trinitrate during physical exercise and during high ambient temperature. American Heart Journal 112: 537–541, 1986PubMedCrossRefGoogle Scholar
  7. Berger M, Cüppers HJ, Hegner H, Jörgens V, Berchtold P. Absorption kinetics and biologic effects of subcutancously injected insulin preparations. Diabetes Care 5: 77–91, 1982PubMedCrossRefGoogle Scholar
  8. Bowdle TA, Patel IH, Levy RH, Wilensky AJ. The influence of free fatty acids on valproic acid plasma protein binding during fasting in normal humans. European Journal of Clinical Pharmacology 23: 343–347, 1982PubMedCrossRefGoogle Scholar
  9. Brouns F. Saris WHM. Rehrer NJ. Abdominal complaints and gastrointestinal function during long-lasting exercise. International Journal of Sports Medicine 8: 175–189, 1987PubMedCrossRefGoogle Scholar
  10. Castenfors J. Renal function during prolonged exercise. Annals of the New York Academy of Science 301: 151–159, 1977CrossRefGoogle Scholar
  11. Clausen JP. Effect of physical training on cardiovascular adjustment to exercise in man. Physiological Reviews 57: 779–815, 1977PubMedGoogle Scholar
  12. Cordain L, Latin RW, Bchnke JJ. The effects of an anaerobic running program on bowel transit time. Journal of Sports Medicine 26: 101–104, 1986Google Scholar
  13. Costill DL. Sweating: its composition and effects on body fluids. Annals of the New York Academy of Sciences 301: 160–174, 1977PubMedCrossRefGoogle Scholar
  14. Coyle JD, Lima JJ. Procainamide. In Evans et al. (Eds) Applied pharmacokinetics: principles of therapeutic drug monitoring, pp. 682–711, Applied Therapeutics, Spokane, 1986Google Scholar
  15. Danon A, Ben-Shimon S, Ben-Zvi Z. Effects of exercise and heat exposure on percutaneous absorption of methyl salicylate. European Journal of Clinical Pharmacology 31: 49–52, 1986PubMedCrossRefGoogle Scholar
  16. Døssing M. Effect of acute and chronic exercise on hepatic drug metabolism. Clinical Pharmacokinetics 10: 426–431, 1985PubMedCrossRefGoogle Scholar
  17. Felig P. Metabolic and endocrine disorders and exercise. In Bove et al. (Eds) Exercise medicine: physiological principles and clinical applications, pp. 305–320, Academic Press. New York. 1983Google Scholar
  18. Fernqvist E, Linde B, Östman J, Gunnarsson R. Effect of physical exercise on insulin absorption in insulin-dependent diabetics: a comparison between human and porcine insulin. Clinical Physiology 6: 489–498, 1986PubMedCrossRefGoogle Scholar
  19. Fred HL. Reflections on a 100-mile run: effects of aspirin therapy. Medicine and Science in Sports and Exercise 1: 212–215, 1980Google Scholar
  20. Gisolfi CV, Wenger CB. Temperature regulation during exercise: old concepts, new ideas. Exercise and Sport Sciences Reviews 12: 339–372, 1984PubMedCrossRefGoogle Scholar
  21. Gollnick PD, Bayly WM, Hodgson DR. Exercise intensity, training, diet and lactate concentration in muscle and blood. Medicine and Science in Sports and Exercise 18: 334–340, 1986PubMedCrossRefGoogle Scholar
  22. Hagenfeldt L. Metabolism of free fatty acids and ketone bodies during exercise in normal and diabetic man. Diabetes 28 (Suppl. 1): 66–70, 1979PubMedGoogle Scholar
  23. Henry JA, Iliopoulou A, Kaye CM, Sankey MG, Turner P. Changes in plasma concentrations of acebutolol, propranolol and indomethacin during physical exercise. Life Sciences 28: 1925–1929, 1981PubMedCrossRefGoogle Scholar
  24. Hurwitz GA, Webb JG, Walle T, Bai SA, Daniell HB, et al. Exercise-induced increments in plasma levels of propranolol and noradrenaline. British Journal of Clinical Pharmacology 16: 599–608, 1983PubMedCrossRefGoogle Scholar
  25. Jogestrand T, Andersson K. Effect of physical exercise on the pharmacokinelics of digoxin during maintenance treatment. Journal of Cardiovascular Pharmacology 14: 73–76, 1989PubMedCrossRefGoogle Scholar
  26. Jogestrand T, Sundqvist K. Effect of physical exercise on the digoxin concentrations in skeletal muscle and serum in man. Clinical Physiology 1: 99–104, 1981CrossRefGoogle Scholar
  27. Johnson JM. Regulation of skin circulation during prolonged exercise. Annals of the New York Academy of Sciences 301: 195–212, 1977PubMedCrossRefGoogle Scholar
  28. Joreteg T, Jogestrand T. Physical exercise and digoxin binding to skeletal muscle: relation to exercise intensity. European Journal of Clinical Pharmacology 25: 585–588, 1983PubMedCrossRefGoogle Scholar
  29. Joreteg T, Jogestrand T. Physical exercise and binding of digoxin to skeletal muscle — effect of activation frequency. European Journal of Clinical Pharmacology 27: 567–570, 1984PubMedCrossRefGoogle Scholar
  30. Kemmer FW, Berchtold P, Berger M, Starke A, Cüppers HJ, et al. Exercise-induced fall of blood glucose in insulin-treated diabetics unrelated to alteration of insulin mobilization. Diabetes 28: 1131–1137, 1979PubMedGoogle Scholar
  31. Kligman AM. A biological brief on percutaneous absorption. Drug Development and Industrial Pharmacy 9: 521–560, 1983CrossRefGoogle Scholar
  32. Klotz U, Lücke C. Physical exercise and disposition of diazepam. British Journal of Clinical Pharmacology 5: 349–350, 1978CrossRefGoogle Scholar
  33. Koivisto VA, Felig P. Effects of leg exercise on insulin absorption in diabetic patients. New England Journal of Medicine 298: 79–83, 1978PubMedCrossRefGoogle Scholar
  34. Linde B. Dissociation of insulin absorption and blood flow during massage of a subcutaneous injection site. Diabetes Care 9: 570–574, 1986PubMedCrossRefGoogle Scholar
  35. Lowenthal DT, Broderman SJ. The effects of exercise on genitourinary function. In Bove et al. (Eds) Exercise medicine: physiological principles and clinical applications, pp. 321–334, Academic Press, New York, 1983Google Scholar
  36. Lüllmann H, Peters T. Action of cardiac glycosides on the excitation-contraction coupling in heart muscle. Progress in Pharmacology 2: 3–57, 1979Google Scholar
  37. Lüllmann H, Peters T, Ziegler A. Kinetic events determining the effects of cardiac glycosides. Trends in Pharmacological Sciences 1: 102–106, 1979CrossRefGoogle Scholar
  38. McInnes GT, Brodie MJ. Concentration-effect relationships for oxprenolol in patients with essential hypertension. British Journal of Clinical Pharmacology 25: 539–545, 1988PubMedCrossRefGoogle Scholar
  39. Mason WD, Kochak G, Winer N, Cohen I. Effect of exercise on renal clearance of atenolol. Journal of Pharmaceutical Sciences 69: 344–345, 1980PubMedCrossRefGoogle Scholar
  40. Monks A, Richens A. Serum protein binding of valproic acid and its displacement by palmitic acid in vitro. British Journal of Clinical Pharmacology 8: 187–188, 1979PubMedCrossRefGoogle Scholar
  41. Mooy J, Arends B, von Kemenade J. Böhm R, Rahn KH, Van Baak M. Influence of prolonged submaximal exercise on the pharmacokinetics of verapamil in humans. Journal of Cardiovascular Pharmacology 8: 940–942, 1986PubMedCrossRefGoogle Scholar
  42. Mundie TG, Pamplin III CL, Phillips YY, Smallridge RC. Effect of exercise in sheep on the absorption of intramuscular atropine sulfate. Pharmacology 37: 132–136, 1988PubMedCrossRefGoogle Scholar
  43. Nadel ER. Recent advances in temperature regulation during exercise in humans. Federation Proceedings 44: 2286–2292, 1985PubMedGoogle Scholar
  44. Patel IH, Levy RH. Valproic acid binding to human serum albumin and determination of free fraction in the presence of anticonvulsants and free fatty acids. Epilepsia 20: 85–90, 1979PubMedCrossRefGoogle Scholar
  45. Poortmans JR. Exercise and renal function. Exercise and Sport Sciences Reviews 5: 255–294, 1977PubMedCrossRefGoogle Scholar
  46. Powis G, Snow DH. The effects of exercise and adrenaline infusion upon the blood levels of propranolol and antipyrine in the horse. Journal of Pharmacology and Experimental Therapeutics 205: 725–731, 1978PubMedGoogle Scholar
  47. Rowell LB. Human cardiovascular adjustments to exercise and thermal stress. Physiological Reviews 54: 75–159, 1974PubMedGoogle Scholar
  48. Saltin B, Hermansen L. Esophageal, rectal, and muscle temperature during exercise. Journal of Applied Physiology 21: 1757–1762, 1966PubMedGoogle Scholar
  49. Schlaeffer F, Engelberg I, Kaplanski J, Danon A. Effects of exercise and environmental heat on theophylline kinetics. Respiration 45: 438–442, 1984PubMedCrossRefGoogle Scholar
  50. Simko V. Physical exercise and the prevention of atherosclerosis and cholesterol gall stones. Postgraduale Medical Journal 54: 270–277, 1978CrossRefGoogle Scholar
  51. Smolander J, Kolari P, Korhonen O, Ilmarinen R. Skin blood flow during incremental exercise in a thermoneutral and hot dry environment. European Journal of Applied Physiology 56: 273–280, 1987CrossRefGoogle Scholar
  52. Swartz RD, Sidell FR. Effects of heal and exercise on the elimination of pralidoxime in man. Clinical Pharmacology and Therapeutics 14: 83–89, 1973PubMedGoogle Scholar
  53. Swartz RD, Sidell FR, Cucinell SA. Effects of physical stress on the disposition of drugs eliminated by the liver in man. Journal of Pharmacology and Experimental Therapeutics 188: 1–7, 1974PubMedGoogle Scholar
  54. Sweeney GD. Drugs — some basic concepts. Medicine and Science in Sports and Exercise 13: 247–251, 1981PubMedCrossRefGoogle Scholar
  55. Theilade P, Hansen JM, Skovsted L, kampmann JP. Effect of exercise on thyroid parameters and on metabolic clearance rate of antipyrine in man. Ada Endocrinologica 92: 271–276, 1979Google Scholar
  56. Verstappen FTJ. Van Baak MA. Exercise capacity, energy metabolism, and beta-adrenoceptor blockade: comparison between a beta l-selective and a non-selective beta blocker. European Journal of Applied Physiology 56: 712–718, 1987CrossRefGoogle Scholar
  57. Weber S, de Lauture D, Rey E, Darragon I, Severins JP, et al. The effects of moderate sustained exercise on the pharmacokinetics of nitroglycerine. British Journal of Clinical Pharmacology 23: 103–105, 1987PubMedCrossRefGoogle Scholar
  58. Ylitalo P, Hinkka H. Effect of exercise on plasma levels and urinary excretion of sulphadimidine and procainamide. International Journal of Clinical Pharmacology Therapeutics and Toxicology 23: 548–553, 1985Google Scholar
  59. Ylitalo P, Hinkka H, Neuvonen PJ. Effect of exercise on the serum level and urinary excretion of letracycline, doxycycline and sulphamcthizole. European Journal of Clinical Pharmacology 12: 367–373, 1977PubMedCrossRefGoogle Scholar

Copyright information

© Adis International Limited 1990

Authors and Affiliations

  • M. A. van Baak
    • 1
  1. 1.Department of Human BiologyUniversity of LimburgMaastrichtThe Netherlands

Personalised recommendations